An Atomistic View on Human Hemoglobin Carbon Monoxide Migration Processes  by Lucas, M. Fátima & Guallar, Víctor
Biophysical Journal Volume 102 February 2012 887–896 887An Atomistic View on Human Hemoglobin Carbon Monoxide
Migration ProcessesM. Fa´tima Lucas† and Vı´ctor Guallar†‡*
†Joint BSC-IRB Research Program in Computational Biology, Barcelona Supercomputing Center, Barcelona, Spain; and ‡Institucio´ Catalana
de Recerca i Estudis Avanc¸ats (ICREA), Barcelona, SpainABSTRACT A significant amount of work has been devoted to obtaining a detailed atomistic knowledge of the human hemo-
globin mechanism. Despite this impressive research, to date, the ligand diffusion processes remain unclear and controversial.
Using recently developed computational techniques, PELE, we are capable of addressing the ligand migration processes. First,
the methodology was tested on myoglobin’s CO migration, and the results were compared with the wealth of theoretical and
experimental studies. Then, we explored both hemoglobin tense and relaxed states and identified the differences between
the a-and b-subunits. Our results indicate that the proximal site, equivalent to the Xe1 cavity in myoglobin, is never visited.
Furthermore, strategically positioned residues alter the diffusion processes within hemoglobin’s subunits and suggest that
multiple pathways exist, especially diversified in the a-globins. A significant dependency of the ligand dynamics on the tertiary
structure is also observed.INTRODUCTIONGlobins are heme-containing proteins involved in the trans-
port and storage of molecular oxygen (O2). For many years,
myoglobin (Mb) has been the preferentially studied globin
both experimentally and theoretically (1–5). Capable of
reversible oxygenation, it has served as a prototype for struc-
ture-function relationship studies of more complex systems.
Hemoglobin (Hb), in contrast, constitutes a challenge for the
study of protein structural dynamics, given its complexity
and cooperativity effects between subunits. Adult human
hemoglobin is a tetrameric (a1b2 a2b1) protein containing
two different subunits called a-globin and b-globin, each
of which holds a heme group. The binding pocket, similar
in both globins, protects the iron atom from the solvent,
and for this reason, it is essential for ligands to migrate
from solution through the protein to reach the active site.
Examination of their crystal structures, however, does not
show any obvious channels for diffusion, and so it has
become clear that protein flexibility is required (6–8).
The processes by which ligands gain access to the active
site has been a subject of research for many years, and it is
now well known that internal cavities play an important role
(3,9). These are normally packing defects that reduce the
overall thermodynamic stability of a protein (10,11), and
it has been postulated that their presence must have a func-
tional purpose (12,13). In Mb, the most important of these
intermediate docking sites are commonly known as the
distal site and the xenon (Xe) cavities, Xe1 (located at the
proximal site)–Xe4 (9). Once the ligand (O2, CO, etc.) is
dissociated from the iron, the primary docking site is found
in the distal pocket, where the ligand remains orientedSubmitted September 14, 2011, and accepted for publication January 11,
2012.
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ring (14). Photodissociated CO has also been observed at
secondary docking positions that coincide with two of the
xenon-binding sites (namely Xe1 and Xe4) (15–17) and
several passageways and bottlenecks between paths have
been uncovered. The idea that the progress of the ligand
in and out of the protein involves the rotation of the side
chain of the distal histidine 64 (E7) was proposed over 40
years ago by Perutz et al (18). This histidine-gated hypoth-
esis was later supported on experimental work (19–22), and
it is now recognized that the commonly known distal
pathway is comprised of Leu-29, Phe-33, Phe-43, Phe-46,
His-64, and Val-68. Most studies indicate that this is the
most favorable and shortest pathway for ligands to reach
or escape the heme (20). In addition, there is evidence for
other paths on the distal side of the protein as well as passing
by the experimentally observed xenon sites (23,24).
Many years of intense research was necessary to unravel
the putative network of pathways known nowadays in Mb
(3,25–29). A quick search through the literature, on the
other hand, shows a scarce amount of information on diffu-
sion pathways in Hb. The complexity of the structure makes
it difficult to extract experimental information and limits the
use of theoretical tools. Work by Birukou et al., in which the
distal histidine was replaced by several amino acids, shows
differences between Hb’s subunits (30,31). Geminate and
bimolecular rate studies on several mutants—Leu(b10),
Val(E11) and Leu(G8), all present in the distal pocket in
both a-and b-units—seems to favor the existence of one
main exit from the protein (32). At the theoretical level,
a study by Mouawad et al. (33) has been reported on human
Hb using steered molecular dynamics (MD), where the
formation of transient internal cavities and passageways
has been reported. Further work on a smaller dimeric Hb
of Scapharca inaequivalvis also proposed the existence ofdoi: 10.1016/j.bpj.2012.01.011
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exposed to high-pressure Xe display heterogeneous
behavior (35). A work just made available, where unbiased
MD simulations were performed on the isolated a-chain
of Hb, shows internal hydrophobic pockets and evaluates
ligand rebinding kinetics (36).
Here, we have used PELE (Protein Energy Landscape
Exploration), a recently developed technique, to present a
complete atomistic exploration of the CO migration in
human Hb as well as Mb, which was used as a test system.
PELE combines a Monte Carlo stochastic approach with
protein structure prediction algorithms, and it is capable
of accurately reproducing long-timescale processes in
only a few hours of CPU (37–39). We have applied PELE
on the high-affinity R state and the low-affinity T state,
and have assessed the differences in diffusion processes.
Hemoglobin’s a-and b-units were investigated individually,
and the results show that the two chains are different not
only structurally but also functionally. We have identified
passages by the distal side equivalent to the ones found in
Mb and show a set of other alternatives for the ligand’s
escape.METHODS
In this work, PELE is used to map carbon monoxide entry/escape routes in
Mb and Hb. The long-timescale dynamics associated with these processes
are easily accessible to PELE because this program combines a steered
stochastic approach with protein structure prediction methods. The algo-
rithm involves the consecutive iteration of three main moves: a ligand
and protein (backbone) perturbation, a side-chain sampling, and a minimi-
zation (40,41) The procedure begins by generating a local perturbation to
the ligand and/or the protein. Ligand perturbation involves a translation
and rotation of the center of mass of the ligand. Protein perturbations are
based on the displacement of a-carbon according to an anisotropic network
model (ANM), a simple model for normal-mode analysis (42). The a-
carbons are displaced based on a randomly picked low eigenvector (or
a combination of them) obtained in the ANM approach. The system is
then minimized with a harmonic constraint on each displaced a-carbon.
The algorithm is also capable of pinpointing the most excited side chains,
i.e., the ones experiencing the largest changes in energy as a consequence of
the ANM move. These are then included in the subsequent side-chain
prediction step. For the side-chain sampling, the algorithm proceeds by
optimally arranging all side chains local to the ligand (within a determined
distance), as well as the hot side chains identified in the ANM step (40,41).
In practice, the distance to and number of hot side chains are adjusted so
that the total number of side chains does not exceed 25; larger groups of
side chains will result in poor predictions. The last stage involves the
minimization of a region including, at least, all residues local to the atoms
involved in steps 1 and 2. These three steps compose a move that is accepted
(defining a new minimum) or rejected based on a Metropolis criterion for
a given temperature. The collection of accepted steps forms a stochastic
trajectory. The combination of ligand and protein backbone perturbations
results in an effective exploration of the protein energy landscape (PES)
that is capable of reproducing large conformational changes associated
with ligand migration and has already been shown to produce reliable
results (37,38). In particular, the methodology has been very effective in
reproducing diatomic ligand migration in bacterial Hbs (38). PELE uses
an OPLS (Optimized Potentials for Liquid Simulations) all-atom force
field (43) with an implicit surface-generalized Born (SGB) continuum
solvent model (44).Biophysical Journal 102(4) 887–896Hb and Mb setup
Initial coordinates for the T-state (CO-unligated) and R-state (CO-ligated)
structures were taken from Protein Data Bank (PDB) entries 1A3N (45)
and 1BBB (46), respectively. The CO-ligated Mb structure was obtained
from two structures identified with PDB entries 1A6G (5) and 2MB5
(47). An unligated state was also investigated in which the initial structure
was taken from the protein database with the entry 1A6N (5). Preparation of
the protein structures was assisted by the protein preparation wizard in
the Schro¨dinger package (48). All missing hydrogen atoms were added,
and residues such as arginines and lysines were set to have cationic side
chains, whereas glutamate and aspartate were established to be anionic,
in agreement with the neutral physiological pH. Histidines were visually
inspected and assigned to be delta, epsilon, or doubly protonated in function
of their nearby environment. In particular, Hb His-146 in the b-chains is
known to play a special role, as the higher pH present in peripheral tissues
favors its protonation with release of O2 and the shift to the preferred T
state. For this reason, the tense state was modeled with a fully protonated
histidine 146, whereas in the R state only the delta nitrogen was protonated
(49,50).
In the bound R state, the CO-Fe bond interaction of the chain under study
was removed and the system was minimized within PELE. The parameters
for the heme’s bound and unbound states were derived by quantummechan-
ical/molecular mechanical (QM/MM) geometry optimizations (see below).
In the case of the unligated T state, the CO was also initially placed in the
vicinity of the heme. Two different approaches were adopted: 1), a ligand
migration to the active site from the CD loop area (using PELE); and 2),
a direct insertion of the ligand in the heme cavity followed by side-chain
sampling and minimization. No significant differences in the free ligand
exploration were observed with either method.
For each state, 40 independent trajectories were produced. Each simula-
tion used eight processors, which moved together in exploring the PES
such that if one processor found a different area (4 A˚ away from the average
position), all the other processors would follow it and all processors would
continue the exploration together. The simulations stopped when the ligand
reached solution.CO-phenylalanine correction
Based on the existing evidence of the importance of phenylalanine resi-
dues in ligand migration (29,37), in addition to picosecond time-resolved
x-ray crystallographic studies (51), we investigated the accuracy of the
force field’s description of the CO-Phe stacking interactions. First, we per-
formed some test calculations (available in Fig. S1 and Fig. S2 in the Sup-
porting Material) to establish the acceptable level of theory to be used and
verified that the MP2 (52) with the basis set aug-cc-pvtz was adequate for
the calculations (53). We then prepared 15 models that consisted of
a benzene ring, where CO molecules were placed at five different posi-
tions and at three different distances relative to the ring. We found that
the strongest interaction for the ligand, ~2 kcal/mol, is in the middle of
the ring at 3.5 A˚, in agreement with calculations performed with the ligand
free to optimize. For each model, we compared MP2 and PELE’s OPLS
all-atom force-field interaction energies and realized that the minimum
is 50% underestimated, by ~1 kcal/mol, when using the classical force
field. We have corrected this interaction by adding an attractive Gaussian
term between a phenylalanine ring and a CO molecule at the center of the
ring:
Energy ¼ A  eBðrCÞ2 ;
where A, B, and C adopted the values of 1.0, 0.2, and 3.0, respectively.
In Fig. 1, we can observe two short simulations with (right) and without
(left) the correction term. It is clear that the new potential stabilizes the
ligand near the phenylalanine close to the center of the benzene ring, as
is expected from the MP2 calculations.
FIGURE 1 CO digression near a system composed of three residues, the
central residue being a phenylalanine. The older version of PELE software
was used for the structure on the left, where the corrected versioni was used
for the righthand structure.
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Parameters for all heme structures were derived from QM/MM calcula-
tions. For this, a 10-A˚ water box was added and equilibrated. Finally,
a single snapshot is selected and all waters except for a layer of ~8 A˚ around
the protein are removed. For these particular calculations, the quantum
region consisted of the heme and proximal histidines in the case of the
unbound system. For the hexa-coordinated system, a carbon monoxide
group was also included. These systems were allowed to relax in the protein
matrix, where all residues within 15 A˚ were free, and a complete optimiza-
tion was performed with the QSite (54) QM/MM software. The density
functional method B3LYP (55–59) with the lacvp* (60) (for Fe atoms)
and 6-31G* (61) (for all other atoms) basis sets is used for the quantum
layer, and the OPLS force field (43) is used for the classical part. A
singlet-state Fe2þ is established for the bound state and a quintet state is
used for the unbound state. The electrostatic-potential partial charges
were included in the templates for the heme containing all necessary
bonding and nonbonding parameters (all data are available in the Support-
ing Material).RESULTS
In the first part of this section, the CO ligand migration in
Mb will be revisited. An exhaustive study is presented that
also serves to validate the methodology, given the large
amount of experimental and theoretical data available for
this system. The second part comprises the study of Hb
ligand migration processes.FIGURE 2 View of the carbon monoxide exit passages in Mb. The
protein is shown in cartoon representation with most of the helices labeled.
The ligand, in bead representation, indicates the center of mass of the mole-
cule. Different colors specify the different exit paths, and the pink spheres
identify the xenon sites.Myoglobin
We have initiated the work by exploring Mb’s CO escape
paths. As mentioned in the Methods section, we have added
a correction to the force field used in PELE to adequately
describe the phenylalanine-CO stacking interactions. Sixty
independent simulations were performed (using the 1A6G
structure) with and without the corrections, allowing the
ligand to move freely out of the protein. The nature of the
paths, and the frequency at which the ligand leaves by
each exit, are very similar with either version of the force
field. However, a main difference arises in the amount of
time that the ligand spends in the proximity of the phenylal-anine site. We find that the phenylalanine site, formed by
Phe-33, Phe-43, and Phe-46, is visited in 61% of the trajec-
tories when the corrected potential is used compared to 34%
with the uncorrected potential. We observe that the proximal
site, the Xe1 cavity, is visited more frequently (and for
longer times) with the corrected force field. This is ex-
pected, given that for the ligand to explore the proximal
side of the protein it must pass over Phe-138. Long resi-
dency times in Xe1 are in agreement with crystallographic
studies (15,17,62). Furthermore, the slow geminate recom-
bination phase observed in Mb has been attributed to rebind-
ing after visiting this inner cavity (20). Thus, we believe that
the introduced correction describes in a more accurate way
the real dynamics of these systems. For this reason, and due
to the better agreement with MP2 calculations, all the Hb
simulations were performed using the corrected version of
the force field (Fig. 2).
Fig. 2 shows the different ligand migration paths found
with PELE, along with the experimentally known xenon
sites. The ligand initially populates the primary docking
site (within 4 A˚ of the iron (Fe) atom—constrained by
Leu-29, Leu-32, His-64, Ile-107, and Val-68), where it
remains above the pyrrole C, parallel to the heme plane.
From this point, the ligand has been seen to escape in
63% of the simulations between the heme D propionates
and Phe-43, also known as the distal path (Fig. 2, green).
These results are in good agreement with kinetic analyses
that suggest that ~70–80% of the ligands leave by this
pathway (20,63). In some of these trajectories, the side chainBiophysical Journal 102(4) 887–896
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ligand, also consistent with the histidine gate hypothesis
(18). We also found what we will call here the phenylalanine
pathway (PHE path), similarly observed in previous calcula-
tions (4,29,37), having as portal residues Leu-29, Phe-33,
and Phe-43 (Fig. 2, orange). Going in the opposite direction,
and passing by the Xe4 site, the ligand escapes at the AB
helix corner (passing through both sides of the G helix) by
the path identified in blue. For the exit on the left side (to
the B helix side in Fig. 2), it is necessary for Arg-118 to
undergo considerable side-chain movement, whereas on
the right side (toward helix A), the His-119 allows the
passage of the ligand to the solvent. In the case of the paths
shown in Fig. 2, in brown, 17% of the trajectories find their
exit near the EF corner, passing the Xe3 site or in the prox-
imity of the A helix. The four docking sites are identified in
the figure: Xe1 on the proximal side of the heme, Xe2 next
to Xe1 and Phe-128, Xe3 close to the EF corner, and Xe4 on
the distal side (Fig. 2, pink spheres; the cavities are repre-
sented as identical spheres for simplicity purposes only
and do not represent the actual size or shape of the cavities).
In addition to 1A6G, we have also investigated ligand
migration processes for two other initial Mb structures.
The two systems correspond to another ligated structure,
2MB5 (used also in a previous MD study by Ruscio et al.
(64)), and an unligated (apo) structure, 1A6N. Calculations
show that the passages in all these systems are identical,
with only the addition of a new path found in 2MB5 (with
a frequency of <10%), where the ligand exits by the prox-
imal side of the heme after visiting the Xe1 site. This
passage was not seen in the calculations with the other
ligated structure, 1A6G, but interestingly, it was reported
in the Ruscio et al. MD study (64) using 2MB5 as initial
coordinates. The frequency with which each passage is
taken, however, changes considerably when comparing the
ligated or unligated structures. For the other initial ligated
state, 2MB5, the main exit path is found to be by the distal
path (~53%); thus, together with the phenylalanine path, this
accounts for 70% of the exits by the distal side, in close
agreement with the 1A6G simulation. The unligated state
presents a reduced digression through the distal path with
only 12.5% choosing this gate. The main exits, previously
identified as the brown and blue paths, with 42.5% and
22.5%, respectively, occur through the protein matrix. These
differences between ligated and unligated states will be
further debated in the Discussion section.
An impressive amount of experimental and theoretical
data are available in literature on Mb’s ligand diffusion
processes. Single-mutation studies have shown that the
substitution of His-64, Phe-43, and Phe-46 for a smaller
residue leads to an increase in the rate constant for O2 entry,
which supports the importance of these residues in the histi-
dine gate hypothesis (20). However, the replacement of
these amino acids by tryptophan does not annihilate ligand
binding, which puts forward the idea of other possible path-Biophysical Journal 102(4) 887–896ways. Furthermore, it has been shown that the escape rates
of the ligand are not significantly affected by a considerable
number of single mutations. Scott and Gibson demonstrated
that filling the Xe1 and Xe4 sites with xenon gas eliminated
the slow phases observed for geminate rebinding but
produced little change in the total amount of geminate
recombination, which could explain the small effect on
single mutations of residues away from the heme (65).
This evidence seems to open the possibility of several path-
ways with similar affinity for the ligand’s escape. This is
further supported by the work by Huang and Boxer (24),
where clusters of residues were mutated simultaneously.
In addition to experimental studies, much computational
work has also been dedicated to the research of ligand
migration processes in Mb. Both theoretical and experi-
mental information seem to point to the coexistence of
several paths, but the ligand appears to have a preferential
escape route by the distal path (4,20,22,24,28,37,66–71).
A recent article (71), where the CO diffusion process was
investigated by reconstructing a three-dimensional poten-
tial-of-mean-force landscape on fully atomistic MD simula-
tion, shows all minima in agreement with the distal pocket
and xenon sites. An extensive MD study performed by
Ruscio et al. (64) also identifies the distal path as the
preferential exit and entrance passage occurring in ~50%
of the simulations. As indicated above, when using the
same initial coordinates we obtain a quantitative agreement,
with 53% of exits by the distal path. Thus, the pathway anal-
ysis exploration with PELE is equivalent to that produced
with long MD, but at a fraction of the computational cost.
For Mb, each trajectory took ~10 h. With four processors,
this added up to 40 CPU h/trajectory, thus requiring 2400
CPU h for 60 trajectories run, which is ~4 days in a 24
CPU cluster. Furthermore, since the methodology involves
mostly local perturbations (ligand translation, side-chain
prediction of residues around the ligand, etc.), it does scale
nicely with size, making it an ideal tool to target complex
systems like human Hb.Hemoglobin
In this section, we will present the ligand diffusion processes
for human Hb using PELE. The high-affinity, ligated (R) and
the low-affinity unligated (T) states, as well as the a-and
b-units, were studied. We produced 40 independent trajecto-
ries for each system. During the simulation, backbone pertur-
bation is only added to the chain where the ligand is
dissociated. Thus, only tertiary changes are allowed in the
chain under study, with the overall quaternary structure being
fairly constant throughout the simulation. In short simula-
tions, i.e., when the ligand escapes quickly to the solvent,
we do not observe considerable changes in the protein’s
tertiary structure, but in extended simulations, where the
ligand remains trapped in the protein matrix longer, the scis-
sion of the Fe-CO bond and consequent retraction of the
Diffusion Processes in Human Hemoglobin 891proximal histidine induces changes in the nearby EF chains.
The E chain is seen to approach the heme site, whereas the
F chain moves away from it. This tertiary movement is
observed in the crystals along the R-to-T transition and has
been clearly characterized in Mb (72).Ligated R state
a-Globin
Just as we observed for Mb, the ligand, initially in the active
site, explores the distal cavity and is limited by the presence
of residues His-58, Val-62, Leu-29, and Leu-101. We find
that from 40 trajectories, 35% of the time, the CO molecule
escapes the protein by the PHE path site. The ligand moves
to the phenylalanine cavity close to Phe-33 and Phe-43 and
exits the protein between Lys-40 and Leu-48. There are two
possibilities for bypassing Phe-33, either between the three
phenylalanines—33, 43, and 46—or behind Phe-33. In
Fig. 3, we can see the main paths found, as well as the
exit frequencies for both the R and T states of Hb’s a-and
b-chains.
We have also found that in 7% of the simulations, the
ligand molecule escapes from between the heme D propio-
nate and Phe-43, surpassing the proximal histidine over the
C and D pyrrole rings. This passage is equivalent to the
distal path in Mb and is shown in green in Fig. 3. There
are a number of different migration pathways that exploreFIGURE 3 Schematic representation of the carbon monoxide exit
passages in human Hb. The table contains information concerning the
percentage of ligands that exit by each path shown in the figure.the interior of the protein, the combination of which repre-
sent almost 60% of the trajectories. In all situations, the
ligand starts by exploring a cavity bordered by residues
Gly-25, Val-62, Leu-101, and Leu-105. From here, the
ligand can escape by the brown path between the G and H
helices, where it finds the solvent or moves into the internal
a2b2 cavity of Hb. Fig. S5 shows the exploration of the inte-
rior of the protein and the exit. The other path shown in blue
explores a second large cavity comprised of the residues
Trp-14, Ala-21, Val-70, Leu-105, and Leu-109. Trp-14
exhibits large movements of the side chain to allow the
ligand to be accommodated in this cavity. In the blue path,
the ligand exits near the AB corner.
For the Hb Ra state we find that the ligand never explores
the proximal site. Our results show that for Mb, in all
instances where the proximal side of the heme is visited,
Phe-138 must move to allow the ligand’s passage. This
residue appears to have a gate function to that flank of the
heme, which has been seen before in MD simulations
(70). Hb, in contrast, does not have this phenylalanine,
and instead, Val-132 is found in an equivalent position for
the a-unit.
b-Globin
The diffusion processes in Rb Hb indicate essentially only
one main pathway, the distal path (95%), with only 5% of
the trajectories moving toward the inner side of the protein.
The ligand begins by occupying the distal pocket, where
it remains (as always) parallel to the heme. In this globin,
the exit by the distal path follows two possible trends: the
ligand can move close to Phe-41 and Phe-42 over the
pyrrole ring D or, on the other side of the heme, over pyrrole
A, exiting in the vicinity of the A propionate. We also
observe that in some simulations, the ligand resides close
to Phe-42 and Phe-45, occupying the phenylalanine site
but never exiting from the CD loop. In addition to the distal
path, on very few occasions, we also see the ligand exiting
close to the AB corner, shown in blue in Figs. 2 and 3. To
probe for the existence of cavities in this unit, we performed
10 additional simulations, taking the initial position of CO
from this last trajectory close to Leu-106 and Leu-110, since
the quick exit by the distal path reduced the probability of
finding the ligand inside the protein. In this way, we were
able to identify a cavity flanked by Leu-68, Leu-106, Leu-
110, Phe-71, Ala-138, and Leu-141, as well as the escape
tunnel (blue trajectory) gated by Trp-15 close to the AB
corner. This cavity is similar to the one found in Ra and
has no equivalent in Mb.Unligated T state
a-Globin
In 12% of the simulations, the ligand exited by the PHE
path through the CD loop next to Leu-48 after exploringBiophysical Journal 102(4) 887–896
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22% of the trajectories, with the ligand exiting by either side
of the distal histidine. When the ligand explores the interior
of the protein, a first small cavity is encountered identical to
the one seen previously in the R state. This comprises the
residues Gly-25, Val-62, Leu-101, and Leu-105, and digres-
sion of the ligand from here can occur in two directions:
toward a second cavity near the GH corner or toward the
Val-132 that blocks the passage to the proximal site. The
second cavity also resembles the ones seen in the relaxed
state and is surrounded by the residues Trp-14, Ala-21,
Val-70, Leu-105, and Leu-109. This cavity is highly ex-
plored by the most popular exit passage, represented in
blue (Fig. 3). In this case, we observe that 35% of the trajec-
tories choose this path and exit between the AB and the GH
corners. We have also observed ligand escape by a passage
similar to the previously identified brown path, but in this
case, the ligand moves toward the solvent and not into the
protein as seen in most cases in the R state.
b-Globin
The systematic exploration of the exit paths for the tense
state’s b-subunit proved to be considerably different from
those for the a-subunit, just as we have already seen for
the R conformation. Out of 40 simulations, we observed
that in 58% of the trajectories, the ligand escapes by the
distal path. In 30% of the cases, the ligand explored the
blue path and on very few occasions, the carbon monoxide
exited by the brown and phenylalanine paths.
A small hydrophobic pocket similar to that seen for the
other subunits is found. The cavity is surrounded by the
residues Leu-68, Leu-106, Leu-110, Phe-71, Ala-138, and
Leu-141, the latter responsible for blocking the passage of
the ligand toward the proximal site.DISCUSSION
In the previous section, we presented a full atomistic
description of the escape passages found for Mb and Hb
using PELE. We have used Mb as a model system and
studied three initial structures: two ligated states and one
unligated. The results show that Mb exhibits a diversified
network of passages that are independent of the initial struc-
ture. Essentially, four exits are found for carbon monoxide:
the distal path commonly accepted as the principal escape
from the protein’s active site; the phenylalanine path; and
two exits that explore the inner part of the protein, here
referred to as brown and blue paths. Differences occur in
the frequency at which each path is taken. For the ligated
states, we find prevalence for exit by the distal path (63%
and 53% of the trajectories), in good agreement with exper-
imental observations (20,63). On the other hand, when the
unligated state is studied, the distal path is taken less
frequently (a tendency also observed in Hb), with domi-
nance of the brown exit, close to the Xe3 cavity.Biophysical Journal 102(4) 887–896These results clearly indicate that ligand migration is
significantly coupled to the tertiary structure. Together
with Professor Spiro, we previously showed that the main
tertiary change during ligand binding involves a concerted
rotation in the E and F helix (72). In particular, in the unli-
gated structure, the E helix collapses toward the active site.
We observe here that this collapse partially blocks the
migration of the ligand to the distal site (pushing the ligand
to the interior of the protein). The importance of the tertiary
structure in ligand dynamics was also reported in exquisite
sol-gel encapsulating experiments by the Friedman group
(73). Although our sampling protocol is capable of
observing tertiary R-to-T transitions (as mentioned above),
a description of the reverse direction would necessarily
involve modeling the ligand binding into the iron center.
Independent of the initial state, our results strongly support
the existence of multiple paths, in agreement with computa-
tional and most experimental data (25). We were able to
confirm the histidine gate hypothesis and identify all xenon
sites.
The investigation performed on Hb’s subunits displayed
diffusion processes noticeably unlike those from Mb. One
of the main differences between the two globins is the
exploration of the proximal site. This site, identified in
Mb as the Xe1 cavity, is never visited in Hb. Inspection of
Mb’s escape paths shows that whenever the proximal site
is visited, Phe-138 must rotate its side chain, thus func-
tioning as a gate. Hemoglobin, instead, has a valine (132)
and a leucine (141) for the a-and b-units, respectively.
The phenylalanine side chain is able to perform large rota-
tions, whereas the valine and leucine are essentially rigid.
These differences in structure explain the absence of migra-
tion processes to the proximal side of the protein, which is
known to be more compact (33,74). As mentioned above,
in Mb, the slow phase of geminate rebinding is attributed
to the exploration of this cavity. Interestingly, in Hb the
geminate rebinding is considerably faster (>100 ms1, as
shown recently in Birukou et al. (32)) than in Mb, in agree-
ment with the lack of proximal-site exploration.
Substantial variances between the a-and b-subunits are
also observed. The main statistics from these studies are
summarized in Fig. 4.
It is clear that significant differences arise depending on
the subunit under study. The main exit pathway for both
b-chains is by the distal site (including here all paths leaving
from the distal site, namely, the distal and PHE paths), espe-
cially relevant in the Rb state, where the digression of the
ligand toward the protein matrix is negligible (5%). This
favorable exit by the distal path for the b-chains seems to
result from a combination of factors. The CO molecule
can leave either between the A and D propionate or the
neighboring Phe-42 and Ser-44 close to the CD loop; thus,
the existence of alternative routes should facilitate departure
from the distal path. In addition, the restricted access inside
the protein seems to be the consequence of the proximity of
FIGURE 4 Overall statistics for ligand migration from the active site to
the exterior of the protein. Mb and the R and T states for Hb are shown,
as are the a-and b-subunits.
Diffusion Processes in Human Hemoglobin 893the residues Leu-110, Leu-68, Leu-106, and Val-67. In
particular, the position of Leu-68 is identical to that of the
smaller Ala-63 present in the a-chains. Alternatively, the
a-chains seem to have an intricate network of passages
exploring the protein inner cavities. Furthermore, a limited
number of exits by the distal path are found in these globins.
The existence of a hydrogen bond between the carboxylate
group from heme D propionate and His-45, in a position
equivalent to those of Ser-44 and Asp-44 in the b-unit and
Mb, respectively, limits the movement of the ligand in this
direction. An alternative passage, particularly in the case
of the Ra unit, is through the PHE path, mostly absent in
the b-chains given the replacement of Phe-33 by Leu-32
in Mb and the a-chains. The dissimilar behavior of these
two chains was already shown experimentally, where gemi-
nate rebinding studies point to nonequivalence of the two
subunits (75,76). The different exploration of inner cavities
in the two chains is also supported by recent high-pressure
Xe studies. Birukou et al. showed, for the a-chain, an
increase in the fraction of geminate recombination from
0.28 to 0.43 when adding 4 atm of Xe gas (32). The b-chain
did not show any major difference (decreasing from 0.33 to
0.32). In a similar way, the escape rate for the a-chain
decreased from 24 to 17 ms1 (again, no significant change
is observed in the b-chain). Altogether, the data clearly
indicate a larger inner cavity exploration in the a-chain.
An exhaustive study on mutations (glycine, alanine, leucine,
glutamine, phenylalanine, and tryptophan) of the distal
histidine also reveals differences between the two subunits
(30). In the b-subunits, the rate constant for bimolecular
O2 binding decreases with increasing size of the amino
acid, supporting the idea that the distal histidine acts as
the main gate. However, Birukou et al. (30) find that the
bimolecular rate constant for the a-globins is more complex.
Supporting the hypothesis of multiple pathways, a very
recent study (36) that combines MD simulations and laser
kinetic spectroscopy reveals the presence of several tran-sient cavities in the a-subunit of an isolated Hb. The theoret-
ical study included 140 independent trajectories that display
four main exits. In addition to the traditional distal path, an
exit occurring by what they refer to as the phantom Ph1 site
resembles the PHE path found here and also reported previ-
ously for Mb. In addition, two other routes lead into the
protein matrix, occupying several docking sites, consistent
with the kinetic model proposed. Our results for the a-
subunit T state also show four possible exit passages, in
excellent agreement with the unbiased MD study. For the
Ra state, all paths are identical to those found in the T state,
but in addition, we found digression of the ligand to the
interunit cavity.
Comparing the results for the different Hb states, we find
again a systematic increase in the exits by the distal side
when going from the T to the R state. In the case of the
a-chains, the increase is 35–42.5%, whereas for the b-chain,
an increase from 65% to 95% is observed. As discussed
above for Mb, this increase correlates with the tertiary
displacement (along the T-to-R transition) of the E helix
with respect to the heme group (72). In the R structure,
the helix is located farther away from the heme prosthetic
group, facilitating ligand migration in the distal site.
Mb was seen to present four main cavities, consistent
with the experimentally observed xenon cavities. Hb,
however, shows a more compact proximal site. In the case
of the b-chain, we see that when the ligand explores the inte-
rior of the protein it often becomes trapped in a cavity in
close proximity to Phe-71. Shibayama et al. (74) reported
that photodissociated CO molecules in the b-subunits of
the T state Hb are located in two sites, the distal pocket
and a hydrophobic cavity in the back of the distal pocket,
~8.5 A˚ away from the iron. This cavity is not seen in Mb,
and inspection of the crystal structure shows the pocket
taken by Leu-72, with the rigid side chain occupying the
space of the phenylalanine’s labile benzene ring. The a-
subunits also have a leucine in this same position, but it is
placed farther away from the heme CBB atom, thus allow-
ing enough free space for the ligand to occupy. For the
a-chains, in addition to this first cavity, the ligand is also
found in a second very large pocket placed between the
AB and the GH corners. The existence of inner cavities
close to the distal pocket has been reported previously
(33,35,74,77). Investigation of xenon sites in horse Hb
(78) showed a very different pattern compared to Mb. Two
xenon sites were found: one in chain a-and one in the
b-unit, lying in slightly different positions. The xenon
atom in the a-chain is nearer to the GH corner and that in
the b-chain is closer to the AB corner. More recently, xenon
sites identified in human Hb show very few cavities in the
b-chains, whereas, according to the authors, the a-chains
are populated by a ‘‘constellation of sites’’ that can map
potential paths between the active site and solution (35).
In summary, to the best of our knowledge, this is the first
complete mapping of humanHb’s diatomic ligand pathways.Biophysical Journal 102(4) 887–896
894 Lucas and GuallarThe tense and relaxed states were investigated, and the two
subunits, a and b, were compared. An atomist view is
provided that pinpoints the principal residues involved in
the migration pathways. We find considerable differences
between the a-and b-chains in either conformational state.
The b-chain in both the T and R states appear to have a pref-
erence for exit by the distal path, with few incursions toward
the protein’s matrix. Alternatively, the a-chains display a
more complex network of possible exits. In addition to exit
by the distal site, digressions toward the inside of the protein
are observed. We find heterogeneity of the two globins
repeatedly reported in both experimental and theoretical
studies, and we confirm that unlike those of Mb, subunits
of Hb are not open for CO migration to the proximal site.
A significant dependency of the ligand dynamics with the
tertiary structure is also observed.
The calculations performed with PELE display results in
good agreement with the available experimental and theo-
retical data. The low computational cost of this method
allows for its application in complex systems such as Hb.SUPPORTING MATERIAL
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